Blockchain Registration Transaction Record

Investors Alert: Securities Class Action Lawsuit Against Kyverna Therapeutics, Inc.

Kessler Topaz Meltzer & Check, LLP files securities class action lawsuit against Kyverna Therapeutics, Inc. for alleged false statements. Investors urged to take action before February 7, 2025 deadline. Learn more about the case and potential recovery opportunities.

This news is significant for investors who purchased Kyverna common stock during its IPO, as it highlights alleged false statements made by the company. Investors have the opportunity to seek appointment as a lead plaintiff and potentially recover losses. It serves as a reminder of the importance of due diligence and transparency in the financial markets.